Dr. Robert Schwartz advances Viral Sign’s position as the thought leader in AI-enabled infrared imaging for infectious disease
March 8, 2021, Birmingham, Alabama Via Viral Sign Inc.
Viral Sign Inc. today announced that Dr. Robert G. Schwartz, MD will join the company as Chief Medical Officer for the U.S. market, effective March 1, 2021. Dr. Schwartz will be a senior member of the leadership team at Viral Sign and will work directly with the company’s scientific advisors and its technology partner, Thermofy (Sao Paulo, Brazil).
“I am very pleased that Dr. Schwartz is joining Viral Sign in this critical role,” said Barry Hix, Chief Executive Officer for Viral Sign Inc. “Dr. Schwartz is a distinguished practitioner, researcher, and thought leader in infrared technology for medicine. The addition of Dr. Schwartz, who will work closely with Dr. Marcos Brioschi (President, Brazil Association of Infrared Medicine), the developer of Viral Sign, ensures the commercial path at Viral Sign will be guided by two of the world’s foremost authorities on infrared technology and its application to medical practice.”
Dr. Schwartz shared, “Viral Sign can play a significant role intercepting the transmission of influenza-like illness in the workplace. The opportunity and responsibility facing Viral Sign requires us to consistently pursue insight from research and garner learnings from our vast screening database for infectious disease. I look forward to helping establish Viral Sign as a recognized leader in AI-enabled advanced screening science and, ultimately, helping equip Viral Sign to enter complementary areas of medicine in the future.”
In addition to his role at Viral Sign, Dr. Schwartz will continue to serve patients at his medical practice focused on physical medicine and rehabilitation in Greenville, South Carolina. He will also continue to serve as Chairman of the Board for the American Academy of Thermology, a leadership role that he has held since 2016.
Dr. Schwarz is board certified by the American Board of Physical Medicine & Rehabilitation, American Board of Electrodiagnostic Medicine, and the American Academy of Thermology. He is also a fellow of the Society For Vascular Medicine. He completed his undergraduate work at the University of Michigan and received his medical degree from Wayne State University School of Medicine in Detroit, Michigan. Dr. Schwartz completed his residency at the University of Texas Health Science Center at San Antonio, Texas.
Dr. Schwartz is published in leading medical journals, including Archives of Physical Medicine & Rehabilitation, Journal of Neurological & Orthopedic Medicine & Surgery, Orthopedics, Journal of Orthopedic Medicine, Journal of Back & Musculoskeletal Rehabilitation, Electricity & Magnetism in Biology & Medicine, and Pain Procedures in Clinical Practice. He has served as Medical Director for a number of institutions and organizations, including Physical Medicine & Rehabilitation, St. Francis Community Hospital, South Carolina Reflex Sympathetic Dystrophy Support Group, South Carolina Fibromyalgia Support Group, and the Palmetto Post-Polio and Peripheral Neuropathy Support Group.
About Viral Sign Inc.
Viral Sign is advanced screening science designed to help employers, health systems, and government agencies create site-safe work environments for employees, customers, and visitors. Viral Sign’s advanced screening science is distinguished by the technology’s ability to identify the presence of virus in individuals prior to the onset of fever. To date, over 2 million screens for infectious disease have been conducted using the software in Viral Sign across three continents—South America, North America, and Europe. To learn more about Viral Sign, visit viral-sign.com or follow Viral Sign on LinkedIn, Facebook, and Twitter.